A Note from the Editorial Director: If you haven’t already, it’s time to sit up and take notice of the eye-popping gains Marc Lichtenfeld has been delivering to subscribers of his...(read more
NPS Pharmaceuticals, Inc. (NPSP) recently priced a public offering of 6,000,000 shares at $14.53 a share, with a 30-day over-allotment option for an additional 900,000 shares. NPS...(read more
I wrote an article about NPSP that hit the wire today.
The stock is pricing in over an 80 PE if the drug NPSP is trying to bring to market gets approved. Not much left to keep the price moving higher at this point.
If the drug fails to win FDA approval a very bad day for [...]